1.86 -0.20 (-10.10%)
LGND
Stock Details
Last Trade:1.86 Change:-0.20 (-10.10%) Prev Close:2.06 Open: 1.98 Days Range:1.81 – 2.03 52 Week Range: 1.10 - 5.82 Volume:290235 P/E: N/AEPS:-0.30
View AllRecent Alerts 12/01/08
Recent Alert on 11/26/08 at 10:22am
Rodman & Renshaw Initiates Coverage on Ligand Pharmaceuticals (LGND) with a Market Outperform
Rodman & Renshaw Initiates Coverage on Ligand Pharmaceuticals (LGND) with a Market Outperform
Rodman & Renshaw initiates coverage on Ligand Pharmaceuticals (Nasdaq: LGND) with a Market Outperform. Price target $5. Rodman analyst says, "The Company is reemerging as a focused execution story after a period of volatility and restructuring... Read More
Recent Alert on 11/21/08 at 1:14pm
Unusual 11 Mid-Day Movers 11/21: DISK, LGND, SOLR, AU Higher; BGP, BHS, FL, MED Lower
Unusual 11 Mid-Day Movers 11/21: DISK, LGND, SOLR, AU Higher; BGP, BHS, FL, MED Lower
Recent Alert on 11/21/08 at 9:34am
Morning Movers 11/21: Citigroup (C) Bounces After Relentless Selling, Autodesk (ADSK) Lower On Results
Morning Movers 11/21: Citigroup (C) Bounces After Relentless Selling, Autodesk (ADSK) Lower On Results
Recent Alert on 11/21/08 at 7:24am
Ligand Pharma (LGND) Partner GlaxoSmithKline's Granted Accelerated Approval of PROMACTA
Ligand Pharma (LGND) Partner GlaxoSmithKline's Granted Accelerated Approval of PROMACTA
Recent Alert on 11/21/08 at 7:24am
Ligand Pharma (LGND) Partner GlaxoSmithKline's Granted Accelerated Approval of PROMACTA
Ligand Pharma (LGND) Partner GlaxoSmithKline's Granted Accelerated Approval of PROMACTA
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 12/01/08 at 5:03pm
Form 4 LIGAND PHARMACEUTICALS For: Nov 26 Filed by: BIOTECHNOLOGY VALUE FUND L P
Form 4 LIGAND PHARMACEUTICALS For: Nov 26 Filed by: BIOTECHNOLOGY VALUE FUND L P